Alzheimer Disease | Medical XPRT
Articles & Whitepapers
-
Examining Models of Chronic Obstructive Pulmonary Disease (COPD) and their Application in Other Disease Frameworks
The field of medical science has long utilized disease models, which are systems simulating the progression and expression of a disease, to better understand various illnesses. These models facilitate the study of disease pathology, identifying underlying mechanisms, and developing potential treatments. In the context of respiratory diseases, numerous models have been developed, with a prominent ...
-
Nano-Flow Cytometry: A Revolutionary Tool for Biomedical Research
Nano-flow cytometry is a revolutionary technology that has the potential to transform early disease detection and diagnosis. Nano-flow cytometers are able to detect and analyze individual ...
News
-
Animal Emotional Behavior Tests for Anxiety and Depression Treatment
In today’s fast-paced and stressful society, the prevalence of anxiety and depression has become a significant concern. Emotion-related animal behavior tests aim to provide a good research tool for the study of emotion-associated diseases. ...
FPI Explores the Future of Cognitive Healthcare at the 87th China International Medical Equipment Fair (CMEF)
BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners
Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate
Oligomerix Announces Series B Extension Raise of $2.7 Million to Support Phase 1 Clinical Development
Equipment & Solutions
-
Showcase
Lecanemab - Alzheimer`s Disease Drug
In Alzheimer’s disease soluble, toxic amyloid beta aggregates are believed to contribute to the neurodegenerative process. Lecanemab, a anti amyloid-beta protofibril antibody, selectively binds to these forms of amyloid beta and eliminates them. The antibody’s unique profile is highly selective for amyloid beta oligomers/protofibrils in the brain. BioArctic’s belief is that ...
Upcoming Events
-
Showcase
12th Microbiome & Probiotics R&D and Business Collaboration Forum
Global Engage is pleased to announce the 12th Microbiome, Probiotics & Prebiotics R&D and Business Collaboration Forum, which is confirmed to be held on April 23-24 2024 in The Netherlands and co-located with the 6th Skin Microbiome & Cosmeceuticals Congress. This world-renowned event which attracted 265 industry, academic, and investment leaders last year, enables the discussion of ...